OKYO Pharma Limited

Healthcare

NASDAQ:OKYO · NASDAQ Capital Market

Market Cap $58.89M Beta 0.02 P/E (TTM) -12.3

$1.60 -1.94%

-$0.03 today

52W Low $1.42High $3.35

Vol 0.05M · Avg 0.07M

EPS (TTM) -$0.12Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-27.83%

Period High

$3.27

Period Low

$1.49

Latest

$1.60

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Immix Biopharma, Inc.

NASDAQ:IMMX

$459.70M

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$266.95M

MacroGenics, Inc.

NASDAQ:MGNX

$251.71M

Sol-Gel Technologies Ltd.

NASDAQ:SLGL

$206.36M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$205.72M

Coya Therapeutics, Inc.

NASDAQ:COYA

$86.31M

Pliant Therapeutics, Inc.

NASDAQ:PLRX

$69.97M

Tiziana Life Sciences Ltd

NASDAQ:TLSA

$65.37M

Clene Inc.

NASDAQ:CLNN

$60.20M

Anebulo Pharmaceuticals, Inc.

ANEB

$19.37M

What is the latest OKYO filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does OKYO have?

Intrinsic Alpha currently shows 20 recent filings for OKYO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.